1. Home
  2. WRAP vs IKNA Comparison

WRAP vs IKNA Comparison

Compare WRAP & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WRAP
  • IKNA
  • Stock Information
  • Founded
  • WRAP 2016
  • IKNA 2016
  • Country
  • WRAP United States
  • IKNA United States
  • Employees
  • WRAP N/A
  • IKNA N/A
  • Industry
  • WRAP Ordnance And Accessories
  • IKNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • WRAP Industrials
  • IKNA Health Care
  • Exchange
  • WRAP Nasdaq
  • IKNA Nasdaq
  • Market Cap
  • WRAP 68.8M
  • IKNA 83.0M
  • IPO Year
  • WRAP N/A
  • IKNA 2021
  • Fundamental
  • Price
  • WRAP $1.70
  • IKNA $1.68
  • Analyst Decision
  • WRAP
  • IKNA Buy
  • Analyst Count
  • WRAP 0
  • IKNA 2
  • Target Price
  • WRAP N/A
  • IKNA $3.00
  • AVG Volume (30 Days)
  • WRAP 191.1K
  • IKNA 41.6K
  • Earning Date
  • WRAP 10-15-2024
  • IKNA 11-07-2024
  • Dividend Yield
  • WRAP N/A
  • IKNA N/A
  • EPS Growth
  • WRAP N/A
  • IKNA N/A
  • EPS
  • WRAP N/A
  • IKNA N/A
  • Revenue
  • WRAP $7,269,000.00
  • IKNA $1,844,000.00
  • Revenue This Year
  • WRAP N/A
  • IKNA N/A
  • Revenue Next Year
  • WRAP N/A
  • IKNA N/A
  • P/E Ratio
  • WRAP N/A
  • IKNA N/A
  • Revenue Growth
  • WRAP 0.99
  • IKNA N/A
  • 52 Week Low
  • WRAP $1.21
  • IKNA $1.02
  • 52 Week High
  • WRAP $7.01
  • IKNA $4.63
  • Technical
  • Relative Strength Index (RSI)
  • WRAP 56.79
  • IKNA 51.57
  • Support Level
  • WRAP $1.71
  • IKNA $1.68
  • Resistance Level
  • WRAP $1.93
  • IKNA $1.78
  • Average True Range (ATR)
  • WRAP 0.16
  • IKNA 0.04
  • MACD
  • WRAP 0.01
  • IKNA 0.00
  • Stochastic Oscillator
  • WRAP 61.70
  • IKNA 36.36

About WRAP Wrap Technologies Inc.

Wrap Technologies Inc offers public safety technologies and services. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

Share on Social Networks: